https://www.panabee.com/news/amphastar-pharmaceuticals-earnings-q2-2025-report
Amphastar Pharmaceuticals Earnings Q2 2025 - Report | AMPH News & Analysis
Amphastar's recent results showcased a complex transition, marked by the proprietary drug BAQSIMI driving 33% sequential revenue growth to $53.6 million, even...
amphastar pharmaceuticalsearningsreportnewsanalysis
https://markets.chroniclejournal.com/chroniclejournal/quote/detailedquote?Symbol=NQ%3AAMPH
User | chroniclejournal.com - Amphastar Pharmaceuticals, Inc. - Common Stock (Nasdaq:AMPH) Detailed...
View detailed stock data for Amphastar Pharmaceuticals, Inc. - Common Stock (Nasdaq:AMPH)
amphastar pharmaceuticalscommon stockuser